TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The importance of TGFβ in the natural history of CML is highlighted in a recent paper by Naka et al. [25] which reported that inhibition of TGFβ impaired colony formation in CML and proposed a role for TGFβ inhibition in CML treatment.